Inovio
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Inovio and other ETFs, options, and stocks.About INO
Inovio Pharmaceuticals, Inc. engages in the provision of designed DNA medicines to treat and protect people from infectious diseases, cancer, and diseases associated with human papillomavirus. Its product pipeline includes VGX-3100, INO-3107, INO-5410, INO-4800, and PENNVAX-GP.
CEOJacqueline E. Shea
CEOJacqueline E. Shea
Employees134
Employees134
HeadquartersPlymouth Meeting, Pennsylvania
HeadquartersPlymouth Meeting, Pennsylvania
Founded1983
Founded1983
Employees134
Employees134
INO Key Statistics
Market cap110.61M
Market cap110.61M
Price-Earnings ratio-0.62
Price-Earnings ratio-0.62
Dividend yield—
Dividend yield—
Average volume2.18M
Average volume2.18M
High today$1.60
High today$1.60
Low today$1.60
Low today$1.60
Open price$1.53
Open price$1.53
Volume3.89K
Volume3.89K
52 Week high$2.98
52 Week high$2.98
52 Week low$1.30
52 Week low$1.30
Stock Snapshot
With a market cap of 110.61M, Inovio(INO) trades at $1.60. The stock has a price-to-earnings ratio of -0.62.
As of 2026-01-14, Inovio(INO) stock has fluctuated between $1.60 and $1.60. The current price stands at $1.60, placing the stock 0.0% above today's low and 0.0% off the high.
The Inovio(INO)'s current trading volume is 3.89K, compared to an average daily volume of 2.18M.
During the past year, Inovio(INO) stock moved between $1.30 at its lowest and $2.98 at its peak.
During the past year, Inovio(INO) stock moved between $1.30 at its lowest and $2.98 at its peak.
Analyst ratings
67%
of 6 ratingsBuy
66.7%
Hold
33.3%
Sell
0%
People also own
Based on the portfolios of people who own INO. This list is generated using Robinhood data, and it’s not a recommendation.